AG
IBB icon

Ascent Group’s iShares Biotechnology ETF IBB Stock Holding History

Ascent Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.1M Buy
5,805
+49
+0.9% +$8.42K 0.03% 375
2026
Q1 		$972K Sell
5,756
-153
-3% -$26.2K 0.03% 367
2025
Q4 		$997K Buy
5,909
+1,262
+27% +$205K 0.03% 372
2025
Q3 		$671K Hold
4,647
– – 0.02% 435
2025
Q2 		$588K Hold
4,647
– – 0.02% 434
2025
Q1 		$594K Sell
4,647
-131
-3% -$17.8K 0.03% 426
2024
Q4 		$632K Sell
4,778
-303
-6% -$42.6K 0.05% 341
2024
Q3 		$740K Sell
5,081
-308
-6% -$44.6K 0.06% 323
2024
Q2 		$740K Hold
5,389
– – 0.06% 310
2024
Q1 		$739K Sell
5,389
-657
-11% -$89.7K 0.07% 305
2023
Q4 		$821K Sell
6,046
-246
-4% -$30K 0.08% 281
2023
Q3 		$723K Sell
6,292
-580
-8% -$73.8K 0.08% 267
2023
Q2 		$875K Sell
6,872
-614
-8% -$79.8K 0.1% 252
2023
Q1 		$967K Sell
7,486
-313
-4% -$41K 0.1% 239
2022
Q4 		$1.02M Buy
7,799
+1
+0% +$129 0.12% 216
2022
Q3 		$1M Hold
7,798
– – 0.12% 208
2022
Q2 		$968K Hold
7,798
– – 0.12% 210
2022
Q1 		$1.02M Buy
7,798
+1
+0% +$130 0.12% 219
2021
Q4 		$1M Buy
+7,797
New +$1.21M 0.13% 220

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Ascent Group's IBB Position: Q2 2026 in Review

Ascent Group increased its iShares Biotechnology ETF (IBB) stake by 0.85% in Q2 2026, buying an estimated $8.42K and bringing the position to 5,805 shares worth $1.1M. The position accounts for 0.03% of the portfolio, ranked #375.

Ascent Group first reported a position in IBB in Q4 2021 and has held it in 19 quarters since. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Ascent Group held 5,805 shares of iShares Biotechnology ETF worth $1.1M as of Q2 2026.
  • Ascent Group bought 49 iShares Biotechnology ETF shares in Q2 2026, an estimated $8.42K.
  • iShares Biotechnology ETF made up 0.03% of Ascent Group's portfolio in Q2 2026, its #375 holding.
  • Ascent Group first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 19 quarters since.
  • 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Ascent Group's 13F filing for Q2 2026, filed 3 Aug 2026.